KIT and mantle cell lymphoma: Both patients were associated with a poor clinico-genetic risk profile, e.g. KIT D816V negative MCL and multimutated SM-MDS/MPNu progressing to secondary acute myeloid leukemia even more indicating DECT as a supplementary tool for identification of high-risk disease.